Article metrics

Download PDFPDF

Extended report
Ustekinumab, an anti-IL-12/23 p40 monoclonal antibody, inhibits radiographic progression in patients with active psoriatic arthritis: results of an integrated analysis of radiographic data from the phase 3, multicentre, randomised, double-blind, placebo-controlled PSUMMIT-1 and PSUMMIT-2 trials

 

Online download statistics by month:

Online download statistics by month: February 2014 to July 2020

AbstractFullPdf
Feb 2014784250374
Mar 2014406429481
Apr 2014283209290
May 20141790378458
Jun 2014717191256
Jul 2014342122182
Aug 2014205111132
Sep 2014175118154
Oct 2014158123143
Nov 201412281130
Dec 20141076192
Jan 201511894101
Feb 201513397133
Mar 2015144124136
Apr 2015112100114
May 20151026789
Jun 20151037296
Jul 2015747075
Aug 2015659092
Sep 2015108103107
Oct 2015595766
Nov 2015796573
Dec 2015898292
Jan 2016996884
Feb 2016998580
Mar 2016766883
Apr 2016797082
May 2016946372
Jun 2016767274
Jul 2016674665
Aug 2016835855
Sep 2016877046
Oct 2016845479
Nov 2016703544
Dec 2016553729
Jan 2017634842
Feb 2017254539
Mar 2017197252
Apr 2017178385
May 2017108250
Jun 2017408642
Jul 20171119439
Aug 201713810544
Sep 20171068436
Oct 201715911246
Nov 20171179042
Dec 20171036329
Jan 20181138743
Feb 20181268068
Mar 20181268236
Apr 201836932630
May 201815611532
Jun 201814412150
Jul 2018706016
Aug 2018624625
Sep 20181206823
Oct 2018735728
Nov 2018855931
Dec 2018775617
Jan 201940637733
Feb 2019443417
Mar 201949947335
Apr 2019754232
May 2019844027
Jun 2019593339
Jul 2019402931
Aug 2019765135
Sep 2019413717
Oct 2019634532
Nov 2019695427
Dec 2019674933
Jan 2020463026
Feb 2020594127
Mar 2020544436
Apr 2020453425
May 2020524249
Jun 2020353024
Jul 2020433638
Total1153074626187